BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,099 | -18.3% | 29,130 | -1.3% | 0.37% | -11.6% |
| Q2 2023 | $1,345 | +12.4% | 29,518 | +0.0% | 0.41% | +10.7% |
| Q1 2023 | $1,197 | -19.9% | 29,514 | +0.6% | 0.37% | -24.4% |
| Q4 2022 | $1,495 | -99.9% | 29,330 | +0.6% | 0.50% | -13.6% |
| Q3 2022 | $1,570,000 | -15.4% | 29,145 | +0.9% | 0.57% | -13.1% |
| Q2 2022 | $1,856,000 | -18.4% | 28,894 | -1.5% | 0.66% | -10.9% |
| Q1 2022 | $2,275,000 | -10.6% | 29,340 | -1.0% | 0.74% | -8.1% |
| Q4 2021 | $2,544,000 | +7.3% | 29,640 | +0.5% | 0.80% | -11.0% |
| Q3 2021 | $2,372,000 | +0.3% | 29,497 | +0.3% | 0.90% | +3.5% |
| Q2 2021 | $2,366,000 | -11.7% | 29,397 | -7.5% | 0.87% | -17.2% |
| Q1 2021 | $2,679,000 | +5.4% | 31,770 | +0.3% | 1.06% | -3.5% |
| Q4 2020 | $2,541,000 | +0.2% | 31,669 | +0.4% | 1.09% | -6.9% |
| Q3 2020 | $2,537,000 | -6.2% | 31,552 | +0.4% | 1.18% | -13.0% |
| Q2 2020 | $2,706,000 | +7.0% | 31,428 | +0.9% | 1.35% | -11.5% |
| Q1 2020 | $2,530,000 | -2.4% | 31,161 | +0.6% | 1.52% | +20.0% |
| Q4 2019 | $2,591,000 | -4.1% | 30,990 | +0.4% | 1.27% | -0.9% |
| Q3 2019 | $2,701,000 | +6.6% | 30,876 | -0.2% | 1.28% | +3.9% |
| Q2 2019 | $2,534,000 | 0.0% | 30,941 | -0.7% | 1.24% | -4.6% |
| Q1 2019 | $2,534,000 | +24.1% | 31,167 | +0.4% | 1.30% | +18.9% |
| Q4 2018 | $2,042,000 | -13.8% | 31,029 | +0.9% | 1.09% | -7.2% |
| Q3 2018 | $2,370,000 | +4.9% | 30,746 | +0.4% | 1.17% | +3.7% |
| Q2 2018 | $2,260,000 | +18.1% | 30,610 | +4.1% | 1.13% | +12.7% |
| Q1 2018 | $1,913,000 | +3.3% | 29,405 | +3.3% | 1.00% | +3.7% |
| Q4 2017 | $1,851,000 | +5.1% | 28,461 | +1.4% | 0.97% | -0.6% |
| Q3 2017 | $1,761,000 | +4.1% | 28,070 | +0.5% | 0.97% | -2.3% |
| Q2 2017 | $1,692,000 | +19.7% | 27,941 | +2.5% | 1.00% | +13.6% |
| Q1 2017 | $1,414,000 | +17.4% | 27,260 | +0.4% | 0.88% | +17.4% |
| Q4 2016 | $1,204,000 | -6.3% | 27,160 | +0.6% | 0.75% | -7.4% |
| Q3 2016 | $1,285,000 | +5.8% | 26,990 | +0.5% | 0.81% | +2.7% |
| Q2 2016 | $1,215,000 | +9.6% | 26,862 | -0.5% | 0.79% | +14.2% |
| Q1 2016 | $1,109,000 | +8.5% | 27,000 | +0.8% | 0.69% | +8.0% |
| Q4 2015 | $1,022,000 | +16.9% | 26,782 | +0.7% | 0.64% | +15.0% |
| Q3 2015 | $874,000 | -52.3% | 26,598 | +1.4% | 0.56% | -50.0% |
| Q2 2015 | $1,834,000 | -15.1% | 26,226 | -16.9% | 1.11% | +19.1% |
| Q1 2015 | $2,161,000 | -7.1% | 31,553 | -0.6% | 0.93% | -8.9% |
| Q4 2014 | $2,326,000 | -11.2% | 31,733 | -13.1% | 1.02% | -18.6% |
| Q3 2014 | $2,620,000 | +3.9% | 36,507 | +4.7% | 1.26% | +4.2% |
| Q2 2014 | $2,521,000 | +276.8% | 34,872 | +283.4% | 1.20% | +254.4% |
| Q1 2014 | $669,000 | -19.6% | 9,096 | -24.0% | 0.34% | -17.9% |
| Q4 2013 | $832,000 | -3.8% | 11,967 | -9.1% | 0.41% | -10.0% |
| Q3 2013 | $865,000 | -46.8% | 13,167 | -43.9% | 0.46% | -50.4% |
| Q2 2013 | $1,625,000 | – | 23,464 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |